Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 39% ± 15% | |
peripheral blood | 16 studies | 31% ± 7% | |
brain | 13 studies | 29% ± 13% | |
intestine | 11 studies | 28% ± 10% | |
kidney | 9 studies | 27% ± 7% | |
eye | 6 studies | 29% ± 9% | |
pancreas | 5 studies | 65% ± 27% | |
bone marrow | 5 studies | 29% ± 7% | |
lymph node | 5 studies | 28% ± 11% | |
liver | 5 studies | 31% ± 11% | |
placenta | 4 studies | 47% ± 19% | |
uterus | 4 studies | 50% ± 16% | |
prostate | 4 studies | 24% ± 6% | |
breast | 4 studies | 31% ± 4% | |
adrenal gland | 3 studies | 27% ± 8% | |
skin | 3 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 13597.08 | 459 / 459 | 100% | 286.68 | 1118 / 1118 |
esophagus | 100% | 10782.32 | 1445 / 1445 | 100% | 218.32 | 183 / 183 |
intestine | 100% | 10794.32 | 966 / 966 | 100% | 210.40 | 527 / 527 |
lung | 100% | 12924.44 | 578 / 578 | 100% | 247.09 | 1155 / 1155 |
ovary | 100% | 15714.83 | 180 / 180 | 100% | 208.96 | 430 / 430 |
pancreas | 100% | 16878.45 | 328 / 328 | 100% | 231.89 | 178 / 178 |
prostate | 100% | 11879.52 | 245 / 245 | 100% | 316.90 | 502 / 502 |
stomach | 100% | 9259.47 | 359 / 359 | 100% | 190.10 | 286 / 286 |
uterus | 100% | 15601.38 | 170 / 170 | 100% | 197.67 | 458 / 459 |
brain | 100% | 7427.13 | 2630 / 2642 | 100% | 219.39 | 705 / 705 |
bladder | 100% | 11683.48 | 21 / 21 | 99% | 193.33 | 501 / 504 |
skin | 100% | 14359.48 | 1809 / 1809 | 99% | 309.77 | 469 / 472 |
thymus | 100% | 14937.74 | 653 / 653 | 99% | 245.91 | 601 / 605 |
liver | 100% | 10031.28 | 226 / 226 | 99% | 139.57 | 400 / 406 |
kidney | 100% | 9154.16 | 89 / 89 | 98% | 184.86 | 885 / 901 |
adrenal gland | 100% | 14008.47 | 258 / 258 | 95% | 171.63 | 219 / 230 |
adipose | 100% | 12928.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 15310.71 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 112.14 | 29 / 29 |
muscle | 100% | 9614.62 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8557.62 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 191.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 105.22 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 98% | 227.67 | 78 / 80 |
heart | 97% | 10676.77 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 6094.13 | 839 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902003 | Biological process | regulation of amyloid-beta formation |
GO_0035459 | Biological process | vesicle cargo loading |
GO_0006890 | Biological process | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
GO_0006886 | Biological process | intracellular protein transport |
GO_0035964 | Biological process | COPI-coated vesicle budding |
GO_0032732 | Biological process | positive regulation of interleukin-1 production |
GO_0048199 | Biological process | vesicle targeting, to, from or within Golgi |
GO_0106272 | Biological process | protein localization to ERGIC |
GO_0045055 | Biological process | regulated exocytosis |
GO_0050714 | Biological process | positive regulation of protein secretion |
GO_0007030 | Biological process | Golgi organization |
GO_0106273 | Biological process | cytosol to ERGIC protein transport |
GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
GO_0048205 | Biological process | COPI coating of Golgi vesicle |
GO_0048208 | Biological process | COPII vesicle coating |
GO_0071806 | Biological process | protein transmembrane transport |
GO_0005801 | Cellular component | cis-Golgi network |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0070765 | Cellular component | gamma-secretase complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0030137 | Cellular component | COPI-coated vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0042589 | Cellular component | zymogen granule membrane |
GO_0030140 | Cellular component | trans-Golgi network transport vesicle |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0030134 | Cellular component | COPII-coated ER to Golgi transport vesicle |
GO_0030133 | Cellular component | transport vesicle |
GO_0012507 | Cellular component | ER to Golgi transport vesicle membrane |
GO_0042470 | Cellular component | melanosome |
GO_0019905 | Molecular function | syntaxin binding |
GO_0038024 | Molecular function | cargo receptor activity |
GO_0008320 | Molecular function | protein transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TMED10 |
Protein name | Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (S31I125) (S31III125) (Tmp-21-I) (Transmembrane protein Tmp21) (p23) (p24 family protein delta-1) (p24delta1) (p24delta) Transmembrane p24 trafficking protein 10 |
Synonyms | TMP21 |
Description | FUNCTION: Cargo receptor involved in protein vesicular trafficking and quality control in the endoplasmic reticulum (ER) and Golgi . The p24 protein family is a group of transmembrane proteins that bind coat protein complex I/COPI and coat protein complex II/COPII involved in vesicular trafficking between the membranes . Acts at the lumenal side for incorporation of secretory cargo molecules into transport vesicles and involved in vesicle coat formation at the cytoplasmic side . Mainly functions in the early secretory pathway and cycles between the ER, ER-Golgi intermediate compartment (ERGIC) and Golgi, mediating cargo transport through COPI and COPII-coated vesicles . In COPII vesicle-mediated anterograde transport, involved in the transport of GPI-anchored proteins by acting together with TMED2 as their cargo receptor; the function specifically implies SEC24C and SEC24D of the COPII vesicle coat and lipid raft-like microdomains of the ER . Recognizes GPI anchors structural remodeled in the ER by the GPI inositol-deacylase/PGAP1 and the metallophosphoesterase MPPE1/PGAP5 (By similarity). In COPI vesicle-mediated retrograde transport, involved in the biogenesis of COPI vesicles and vesicle coat recruitment . Involved in trafficking of amyloid beta A4 protein and soluble APP-beta release (independent from the modulation of gamma-secretase activity) . Involved in the KDELR2-mediated retrograde transport of the toxin A subunit (CTX-A-K63)together with COPI and the COOH terminus of KDELR2 (By similarity). On Golgi membranes, acts as a primary receptor for ARF1-GDP, a GTP-binding protein involved in COPI-vesicle formation . Increases coatomer-dependent GTPase-activating activity of ARFGAP2 which mediates the hydrolysis of ARF1-bound GTP and therefore modulates protein trafficking from the Golgi apparatus . Involved in the exocytic trafficking of G protein-coupled receptors F2LR1/PAR2 (trypsin and tryspin-like enzyme receptor), OPRM1 (opioid receptor) and P2RY4 (UTD and UDP receptor) from the Golgi to the plasma membrane, thus contributing to receptor resensitization . In addition to its cargo receptor activity, may also act as a protein channel after oligomerization, facilitating the post-translational entry of leaderless cytoplasmic cargo into the ERGIC . Involved in the translocation into ERGIC, the vesicle entry and the secretion of leaderless cargos (lacking the secretion signal sequence), including the mature form of interleukin 1/IL-1 family members, the alpha-crystallin B chain HSPB5, the carbohydrate-binding proteins galectin-1/LGALS1 and galectin-3/LGALS3, the microtubule-associated protein Tau/MAPT, and the annexin A1/ANXA1; the translocation process is dependent on cargo protein unfolding and enhanced by chaperones HSP90AB1 and HSP90B1/GRP9 . Could also associates with the presenilin-dependent gamma-secretase complex in order to regulate gamma-cleavages of the amyloid beta A4 protein to yield amyloid-beta 40/Abeta40 . . |
Accessions | ENST00000303575.9 ENST00000555873.1 P49755 G3V2K7 |